☆
4.4
Article
Sequential administration of GM-CSF (Sargramostim®) and IL-2 ± autologous vaccine as adjuvant therapy in cutaneous melanoma:: An interim report of a phase II clinical trial
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Rate this paper
The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started